Immtech Pharmaceuticals

From SourceWatch
Jump to navigation Jump to search

Immtech "has an exclusive worldwide license to develop and commercialize patented compounds derived from a proprietary medicinal platform." [1]

Directors

Accessed March 2008: [2]

  • Eric L. Sorkin - Chairman and Chief Executive Officer
  • Cecilia Chan - Executive Director and Board Member
  • David Fleet - Principal, David Fleet Pharmaceutical Industry Consultancy Services, Non-Executive Director, OnMedica Group Ltd. ,Director, IatRx Pharma Ltd.
  • Judy Lau - Chairperson, Convergent Business Group, Hong Kong, PRC
  • Levi Hong Kaye Lee - Queen Mary Hospital, Hong Kong, PRC
  • Donald F. Sinex - Board Director, Devonwood, Inc.

Advisors

  • Dorothy S. Zinberg - Center for Science and International Affairs Kennedy School of Government, Harvard University

Contact

Web: http://www.immtechpharma.com

Resources and articles

Related Sourcewatch articles

References

  1. Home, Immtech Pharmaceuticals, accessed March 19, 2008.
  2. Directors, Immtech Pharmaceuticals, accessed March 19, 2008.